Hans Rollema

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Jotham W. Coe, Paige R. Brooks, Michael G. Vetelino et al. · Journal of Medicinal Chemistry · 2005 · 933 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Hans Rollema, Leslie K. Chambers, J.W. Coe et al. · Neuropharmacology · 2006 · 535 citations

Public Health, Pharmacology, Pharmacotherapy +14

AAPS-FDA Workshop White Paper: Microdialysis Principles, Application and Regulatory Perspectives

Chandra S. Chaurasia, Markus Müller, Edward D. Bashaw et al. · Pharmaceutical Research · 2007 · 314 citations

Pharmacy, Biomedical Engineering, Pharmacology +7

Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects

Karen L. Houseknecht, Alan S. Robertson, William J. Zavadoski et al. · Neuropsychopharmacology · 2006 · 240 citations

Medicine, Endocrinology, Pharmacology +17

The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis

Ben H.C. Westerink, J. Tuntler, G. Damsma et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1987 · 215 citations

Medicine, Neuroscience, Pharmacology +11